BPI
CPRX icon

BFC Planning, Inc.’s Catalyst Pharmaceutical CPRX Stock Holding History

BFC Planning, Inc.’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.44K Hold
173
– – ﹤0.01% 2641
2026
Q1 		$4.28K Hold
173
– – ﹤0.01% 2364
2025
Q4 		$4.04K Hold
173
– – ﹤0.01% 2430
2025
Q3 		$3.41K Buy
+173
New +$3.56K ﹤0.01% 2319
2025
Q2 		– Sell
-13,090
Closed -$317K – 2705
2025
Q1 		$317K Buy
13,090
+1,202
+10% +$27.1K 0.03% 452
2024
Q4 		$248K Buy
+11,888
New +$255K 0.02% 530

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Glazer Capital LLC
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
HBK Investments
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BFC Planning, Inc.'s CPRX Position: Q2 2026 in Review

BFC Planning, Inc. held its Catalyst Pharmaceutical (CPRX) position steady in Q2 2026 at 173 shares worth $5.44K. The position accounts for ﹤0.01% of the portfolio, ranked #2641.

BFC Planning, Inc. first reported a position in CPRX in Q4 2024 and has held it in 6 quarters since. The position peaked at $317K in Q1 2025. 399 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • BFC Planning, Inc. held 173 shares of Catalyst Pharmaceutical worth $5.44K as of Q2 2026.
  • BFC Planning, Inc. left its Catalyst Pharmaceutical share count unchanged in Q2 2026.
  • Catalyst Pharmaceutical made up ﹤0.01% of BFC Planning, Inc.'s portfolio in Q2 2026, its #2641 holding.
  • BFC Planning, Inc. first reported a position in Catalyst Pharmaceutical in Q4 2024 and has held it in 6 quarters since.
  • BFC Planning, Inc.'s Catalyst Pharmaceutical position peaked at $317K in Q1 2025.
  • 399 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.